Abstract
Background: Future developments in adjuvant modalities may require substaging of nodepositive colorectal adenocarcinoma that is accurately indicative of individual prognoses, upon which therapeutic decisions (e.g., choice of agents and intensity of treatment) may be based. This study compares substaging of node-positive colorectal cancer by venous invasion with substaging by three currently used methods, with respect to the ability of each method to define patient subsets that differ significantly in both disease-free and cancer-related survival rates.
Methods: A total of 171 patients with node-positive colorectal cancer, who had undergone potentially curative resection at least 5 years earlier, were retrospectively substaged by the tumor, node, metastasis (TNM) N1/N2, Astler-Coller C1/C2, Gastrointestinal Tumor Study Group (GITSG) C1/C2, and venous invasion (positive/negative) methods. Disease-free and cancer-related survival curves were calculated (by the Kaplan-Meier method) and compared for statistical significance (using the log-rank test).
Results: The separation of disease-free and cancer-related survival curves using the four methods of substaging node-positive colorectal cancer was as follows: TNM, P = .16 (not significant) and P = .12 (not significant); Astler-Coller, P <.01 and P = .006; GITSG, P = .067 (not significant) and P = .03; venous invasion, P = .016 and P = .007, respectively.
Conclusions: Numerical substaging of node-positive colorectal cancer (TNM and GITSG methods) is an inferior predictor of prognosis, compared with substaging by the T value (Astler-Coller) or venous invasion methods. We think that the latter method is the method of choice, because it separates patients who have only lymphatic metastasis from patients who display microscopic hematogenous spread as well. This separation obviously has biological/oncological significance, and it may have practical therapeutic implications in the future.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
National Institutes of Health Consensus Development Conference Statement. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444–1450.
Gordon-Watson C, Dukes CE. The treatment of carcinoma of the rectum with radium. Br J Surg 1929–30;17:365–9.
Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323–32.
Gabriel WB, Dukes CE, Bussey HJR. Lymphatic spread of cancer in the rectum. Br J Surg 1935;23:395–413.
Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;12:309–20.
Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846–51.
Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum: clinico-pathologic correlation and implications for adjuvant therapy. Cancer 1974;34:1278–92.
Gastrointestinal Tumor Study Group. Prolongation of the diseasefree interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465–72.
Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the Dukes’ C class of colorectal cancer. Ann Surg 1986;203:115–22.
Japanese Society for Research for Cancer of the Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Jpn J Surg 1983;13:557–73.
Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987;1:1303–6.
Payne JE. International colorectal carcinoma staging and grading. Dis Colon Rectum 1989;32:282–5.
American Joint Committee on Cancer. Cancer staging manual, 5th edn. Philadelphia: Lippincott-Raven, 1998.
Cox DR. Regression models and life tables. J R Statist Soc B 1972;34:187–220.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457–81.
Cohen AM, Tremiterra S, Candela F, Thaler HT, Sigurdson ER. Prognosis of node-positive colon Cancer. Cancer 1991;67:859–61. Cancer 1967;20:1976–85.
Brown CE, Warren S. Visceral metastasis from rectal carcinoma. Surg Gynecol Obstet 1938;66:611–21.
Dukes CE, Bussey HJR. Venous spread in rectal cancer. Proc R Soc Med 1941;34:571–81.
Sunderland DA. The significance of vein invasion by Cancer of the rectum and sigmoid: a microscopic study of 210 cases. Cancer 1949;2:429–37.
Grinnell RS. Lymphatic metastases of carcinoma of the colon and rectum. Ann Surg 1950;131:494–506.
Swinton NW. Cancer of the colon and rectum: a statistical study of 608 patients. Surg Clin North Am 1959;39:745–53.
Spratt JS Jr., Spjut HJ. Prevalence and prognosis of individual, clinic and pathologic variables associated with colorectal carcinoma. Cancer 1967;20:1976–85.
Copeland EM, Miller LD, Jones RS. Prognostic factors in carcinoma of the colon and rectum. Am J Surg 1968;116:875–81.
Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJR, Morson BC. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980;67:439–42.
Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJR, Morson BC. Spread of rectal cancer within veins: histologic features and clinical significance. Am J Surg 1981;141:15–7.
Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJR, Morson BC. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology 1981;5:141–63.
Steinberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors: the Gastrointestinal Tumor Study Group experience. Cancer 1986;57:1866–70.
Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT. Resectable adenocarcinoma of the rectosigmoid and rectum: the influence of blood vessel invasion. Cancer 1988;61:1417–24.
Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potentially curative surgery of colon cancer. 2. The influence of blood vessel invasion. J Clin Oncol 1988;6:119–27.
Horn A, Dahl O, Morild I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum 1990;33:598–601.
Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum 1991;34:798–804.
Inoue T, Mori M, Shimono R, Kuwano H, Sugimachi K. Vascular invasion of colorectal carcinoma readily visible with certain stains. Dis Colon Rectum 1992;35:34–9.
Ouchi K, Sugawara T, Ono H, et al. Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastases. Cancer 1996;78:2313–7.
Dirschmid K, Lang A, Mathis G, Haid A, Hansen M. Incidence of extramural venous invasion in colorectal carcinoma: findings with a new technique. Hum Pathol 1996;27:1227–30.
Blumberg D, Paty PB, Picon AI, et al. Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg 1998;186:574–80.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sternberg, A., Sibirsky, O., Cohen, D. et al. New Approach to the Substaging of Node-Positive Colorectal Adenocarcinoma. Ann Surg Oncol 6, 161–165 (1999). https://doi.org/10.1007/s10434-999-0161-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-999-0161-x